Pharming Group valuation

PHARM · Euronext Amsterdam · EUR

Compare Pharming Group
€1.08Change from previous close: −3.05%Absolute change: −€0.03

Close · November 20, 2026

Valuation

The P/E ratio is 36.1. The average price target of 4 analysts is €2.24.

Data as of November 22, 2026

Pharming Group compared with similar companies

Pharming Group's P/E (trailing 12 months): 36.1, +145% against the median of a group of 7 similar companies (14.7).

Pharming Group's metrics compared with similar companies
MetricPharming GroupMedian25th–75th percentileBand
P/E (trailing 12 months)36.114.74.92 – 28.1High
Forward P/E32.252.319.9 – 96.9Middle
EV/EBITDA11.713.312.4 – 15.8Low
Price/book2.854.452.62 – 5.35Middle
Price/sales1.984.203.13 – 22.7Low
Gross margin87.7%87.2%71.5% – 93.2%Middle
Operating margin12.8%19.6%-70.7% – 36.9%Middle
Net margin6.3%10.5%0.0% – 43.9%Middle
ROE8.7%16.3%-5.5% – 27.7%Middle
Debt/equity0.390.050.03 – 0.34High

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Other metrics

Valuation multiples

Market cap
€765.47M
Enterprise value
€664.71M
EV/revenue
1.72

Profitability and growth

ROA
6.4%
ROIC
7.7%
Revenue growth (year over year)
20.8%
Earnings growth (year over year)
74.9%

Financial health

Total cash
€189.56M
Total debt
€114.51M
Current ratio
3.23
Quick ratio
2.65
Altman Z-Score
3.90
Piotroski F-Score
5.00

Dividends

Dividend yield
0.0%
Payout ratio
0.0%

Analysts and estimates

Average price target
€2.24
Median price target
€2.27
High price target
€2.50
Low price target
€1.94
Analysts with a price target
4
Consensus
Strong buy
Forward EPS
€0.03
EPS estimate, current year
€0.03

Shares and trading

Beta
0.05
Average volume
8.47M
Shares outstanding
707.78M
Float
673.18M
Institutional ownership
22.2%
Insider ownership
1.0%